PlainRecalls
FDA Drug Moderate Class II Terminated

Omeprazole Delayed-Release Capsules, USP, 20 mg, 1000 count bottles, Rx Only, distributed by Breckenridge Pharmaceutical, Inc., Berlin, CT, Manufactured by Tow Pharmaceutical Europe, S.L., Martorelles (Barcelona), Spain NDC 51991-643-10

Reported: March 24, 2021 Initiated: March 11, 2021 #D-0308-2021

Product Description

Omeprazole Delayed-Release Capsules, USP, 20 mg, 1000 count bottles, Rx Only, distributed by Breckenridge Pharmaceutical, Inc., Berlin, CT, Manufactured by Tow Pharmaceutical Europe, S.L., Martorelles (Barcelona), Spain NDC 51991-643-10

Reason for Recall

Failed Impurities/Degradation Specifications: Out-of-Specification results obtained for unknown impurities during stability testing.

Details

Units Affected
3,146 bottles
Distribution
Product was distributed nationwide
Location
Berlin, CT

Frequently Asked Questions

What product was recalled?
Omeprazole Delayed-Release Capsules, USP, 20 mg, 1000 count bottles, Rx Only, distributed by Breckenridge Pharmaceutical, Inc., Berlin, CT, Manufactured by Tow Pharmaceutical Europe, S.L., Martorelles (Barcelona), Spain NDC 51991-643-10. Recalled by Breckenridge Pharmaceutical, Inc. Units affected: 3,146 bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Out-of-Specification results obtained for unknown impurities during stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 24, 2021. Severity: Moderate. Recall number: D-0308-2021.